You have no items in your shopping cart.
Kaloba EPS 7630 Liquid is a 3-way fast acting formulation containing premium extracts of Pelargonium sidoides, a native South African purple flower. It assists in building the body’s defences against common diseases and protects against the ills and chills that come in winter. Plus, it features a soothing property for your throat, nose and sinus cavities for clearer breathing. Suitable for your whole family, even children age 1 and above!
Kaloba EPS 7630 Liquid introduces the active ingredient, EPs 7630, specially derived from Pelargonium sidoides. This purple-flowering South African plant is a traditional remedy for winter ills and seasonal chills that threaten the throat and respiratory system. Scientific studies show that Kaloba significantly boosts the natural immune response of the body and protects it from winter bugs and ills and infections that manifest as sore throat, runny nose, coughs, and common colds.
Adult and adolescents over 12 take 30 drops (1.5ml) three times daily. Children 6 – 12 take 20 drops (1ml) three times daily. Infants 1 – 5 take 10 drops (0.5ml) three times daily.
In acute cases adults and children over 12 take 40 (2ml) drops three to five times daily.
For best results use Kaloba ® at the first sign of problems and continue for an additional 48 hours after they subside. Kaloba ® can be diluted with liquid.
Each bottle contains:
50ml or 20ml Pelargonium sidoidesextract (ethanolic extract from the roots of Pelargonium sidoides). Glycerol, alcohol by volume 12%, water.
Does not contain:
Gluten, lactose, salt, yeast, preservatives, artificial colours or flavours.
After time, plant-based extracts in liquid form may become cloudy. This does not affect the product’s efficacy. Since Kaloba ® is a natural product, slight variations in colour and taste may occur.
If symptoms persist, please consult your doctor.
Do not take if you are taking blood thinning medication or have an increased tendency to bleed.
Do not use during pregnancy and lactation as no adequate studies available.